AprilSorrellMD
Pediatric Hematology & Oncology • Summit, NJCancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology
Sr. Medical Director, Clinical Research and Development
Dr. Sorrell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
86 Morris Dr
Bristol-Myers Squibb
Summit, NJ 07901
Summary
- Drug Development; Clinical Research and Development; CAR T, IMids, CelMods
Education & Training
City of Hope Comprehensive Cancer CenterPost-Doctoral Fellowship, 2007 - 2009
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1994 - 1997
University of MarylandResidency, Pediatrics, 1992 - 1994
Sinai Hospital of BaltimoreInternship, Pediatrics, 1991 - 1992
University of Oklahoma College of MedicineClass of 1991
Certifications & Licensure
NJ State Medical License 2001 - 2025
TX State Medical License 2014 - 2022
CA State Medical License 2007 - 2015- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Career development award; clinical cancer genetics 2007-2009
Clinical Trials
- Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder Start of enrollment: 2006 Mar 01
- Study of Blood Samples From Newborns With Down Syndrome Start of enrollment: 2009 Feb 23
Publications & Presentations
PubMed
- 66 citationsOral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncolo...Linda C. Stork, Yousif Matloub, Emmett Broxson, Mei La, Rochelle Yanofsky
Blood. 2010-04-08 - 63 citationsImproved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trialJeffrey W. Taub, Jason N. Berman, Johann Hitzler, April D. Sorrell, Norman J. Lacayo
Blood. 2017-06-22 - 127 citationsNatural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: A report from the Children's Oncology Group Study A2971Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing, Joanne M. Hilden, April D. Sorrell
Blood. 2011-12-22
Industry Relationships
- Sr Medical Director, Bristol Myers SquibbCAR-T cell therapy2019 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
